Beone Medicines LTD. balance sheet
At the end of its fiscal year on Dec 31, 2025, Beone Medicines LTD. reported total assets of $8.19B and shareholders' equity of $4.36B. That works out to liabilities equal to 47% of assets, a current ratio of 3.41 (current assets ÷ current liabilities), long-term debt of 0.22× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $405.81M | $1.05B | $2.25B | $1.61B | $5.60B | $8.54B | $6.38B | $5.81B | $5.92B | $8.19B |
| Current assets | $374.40M | $913.50M | $1.94B | $1.17B | $4.96B | $7.61B | $5.21B | $4.20B | $3.99B | $6.23B |
| Cash & equivalents | $87.51M | $239.60M | $712.94M | $618.01M | $1.38B | $4.38B | $3.87B | $3.17B | $2.63B | $4.55B |
| Total liabilities | $52.91M | $362.25M | $496.04M | $633.93M | $1.73B | $2.40B | $2.00B | $2.27B | $2.59B | $3.83B |
| Current liabilities | $35.06M | $149.99M | $246.45M | $310.31M | $1.08B | $1.60B | $1.47B | $1.81B | $2.21B | $1.83B |
| Long-term debt | $17.28M | $9.22M | $40.78M | $83.31M | $183.64M | $202.11M | $209.15M | $197.62M | $166.48M | $961.91M |
| Shareholders' equity | $352.91M | $669.81M | $1.74B | $962.21M | $3.87B | $6.13B | $4.38B | $3.54B | $3.33B | $4.36B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 1651308 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.